1 Case introduction 陳 先 生, 71y/0 96/10/9, Received TURP for BPH at 仁 愛 醫 院, pre-surgery CXR showed an abnormal mass over LUL. 96/10/19 TMUH, He went to Dr. 鍾 OPD for help Abnormal CXR finding Arrange chest CT and admission at 10/22
2 History 70y/o Cigarette 1.5 PPD/day for > 50years, quit for 2 weeks No chemical substance exposure history Denied s/s of cough, sputum, dyspnea, DOE, body weight loss, chest pain, or chest tightness Past history of :Type II DM (for unknown years), BPH s/p TURP Denied any of malignant family history
3 Clinical course 10/22 Admission 10/23 Chest CT 10/24 Bone scan 10/25 CT guide biopsy Discharged for second opinion to 和 信 醫 院, then lost follow up
4 Lab data CBC/DC: BCS: Bl. T. INR APTT PT Baso Eos Mono Lym Neu WBC PLT RDW MCH MCV HCT Hb Ca K Na Alb Bili T GPT GOT Cr BUN
5 CXR 96/10/19 A well-defined patch in the left lung, near the hilum, no central necrosis seen. No bone metastasis seen.
6 CT without contrast A lobulated border, heterogenous mass 4.5x3.8 cm in dimension, at the posterior segment of LUL of lung with focal pleuralitail and hilar attachment.
7 CT with contrast Few of enlarged mediastinal lymphadenopathy at pre-aortic and retrocavalparatracheal regions.
8 D/D of whitish patch in CXR Lung collapse Pleural effusion Consolidation Fibrosis Cavitating lesion Mesothelioma Lung neoplasm
9 Lung collapse Lung area size change Homogenous patch, no lung marking in it Organ deviation, ex: trachea, heart, diaphragm, mediastinum, lung fissure Ribs retraction No definite heart border (if near heart) Lat view
16 Lung neoplasm The coin lesion Irregular, lobulated border Rare calcification Look for metastasis Old film
17 Pathological report Patho report: Microscopically, it shows a picture of adenocarcinoma arranged in solid nests and infiltrative pattern. The carcinoma cells have pleomorphic nuclei, prominent nucleoli, and eosinophilic cytoplasm.
18 Final diagnosis Left lung, upper lobe, NSCLC, ct3n2m0, stage IIIA
19 Discussion of lung cancer The most common cause of cancer mortality worldwide for both men and women. The term lung cancer, or bronchogenic carcinoma: refers to malignancies that originate in the airways or pulmonary parenchyma.
20 Risk factor Smoking account for 90% cause, 1PPD/ day for 40 years folds than other people, the rate will increase accompanied with asbestos approach. Radiation RT for breast cancer or lymphoma Environmental toxins: second-hand smoke, asbestos, radon, metals (arsenic, chromium, and nickel), ionizing radiation, and polycyclic aromatic hydrocarbons
21 Risk factor Pulmonary fibrosis 7 folds Other factors HIV infection, genetic factors, dietary factors No screening test (chest radiography, sputum cytology, or CT) has been shown to reduce mortality from lung cancer. -- except early CT for selected high-risk patient, it can detect stage I lesion (2007)
22 Classification Adenocarcinoma 38%, peripheral Squamous carcinoma 20% Large cell carcinoma 5% Small cell carcinoma 14%, respond to C/T Other non-small cell carcinomas, which cannot be further classified 18% Other 6%
24 Effect Superior vena cava syndrome (SCLC) Pancoast s syndrome (NSCLC) Paraneoplastic phenomena Hypercalcemia (PTH,SCC), SIADH(SCLC), Cushing s syndrome(acth,sclc) Metastasis: Liver LFT, AKP, CT Bone PET, Bone scan, AKP (SCLC) Adrenal gland CT, rarely symptomatic Brain CT
25 Lab Need to check: complete blood count, serum electrolytes, calcium, alkaline phosphatase, albumin, alanine aminotransferase (ALT), aspartate aminotransferase (AST), total bilirubin, and creatinine
26 Diagnostic image (NSCLC) The imaging modalities most commonly used in the staging of lung cancer include CXR, CT, PET, MRI, Bone scan Tumor character: -- Tumor size, -- Presence or absence of satellite nodules, -- Presence, absence, and extent of atelectasis, -- Invasion of adjacent structures
27 Diagnostic image--cxr Prior radiographs can be extremely important as baselines for comparison. Although most lung cancers are visible on chest radiographs, detection of mediastinal lymph node metastases, invasion of the chest wall, and invasion of mediastinal structures cannot be accurately determined
28 Diagnostic image -- CT Should be performed in all patient. The CT should survey an area from base of the neck to below the adrenal glands Intravenous contrast material can be helpful in distinguishing mediastinal structures and assessing potential vascular invasion. Detect metastases of brain, liver, adrenal gland CT is far less helpful in detecting bone metastases.
29 Diagnostic image -- PET FDG-PET improves the detection rate of malignancy compared to conventional diagnostic studies such as CT or radionuclide bone scan, which frequently alters diagnostic management and treatment decisions PET is not suited to the detection of brain metastases due to high glucose uptake
30 Diagnostic image -- MRI MRI may be more accurate than CT in delineating mediastinal or chest wall invasion. MRI may more readily identify tumors involving the superior sulcus or abutting the diaphragm because of its ability to directly visualize the lung apices and diaphragmatic surfaces in the sagittal or coronal planes MRI is the most effective modality for detecting brain metastases. It is also useful in the evaluation of adrenal lesions
31 Diagnostic image Bone scan Increasingly widespread use of PET imaging has virtually replaced bone scans in asymptomatic patients. Advantages of the bone scan include: less time-consuming, wider field of view, and less likely to have false-negative results associated with osteoblastic lesions
32 AJCC TNM Staging system
33 AJCC TNM Staging system
34 AJCC TNM Staging system
35 SCLC staging The two stage system originally introduced by the Veterans' Affairs Lung Study Group (VALSG) is widely utilized in staging of SCLC -- Limited disease is defined as disease confined to the ipsilateral hemithorax and within a single radiotherapy port (corresponding in part to TNM stages I through IIIB).(30~40%) -- Extensive disease is defined as evident metastatic disease outside the ipsilateral hemithorax. (60~70%)
36 SCLC tumor markers Eight SCLC antigen clusters have been identified by segregation analysis, and divided into three groups: neural, epithelial, and neuroendocrine. Because of their epithelial cellular origin, virtually all SCLCs are immunoreactive for keratin and epithelial membrane antigen. Expression of dopa decarboxylase, calcitonin, neuronspecific enolase, chromogranin A, CD56 (neural cell adhesion molecule [NCAM], gastrin releasing peptide (GRP), and insulin-like growth factor-i (IGF-I), also a number of polypeptide hormones, including ACTH and vasopressin
37 Treatment Initial evaluation: Whether a lung cancer is a NSCLC or an SCLC is critical for treatment planning, and a tissue diagnosis is necessary. Staging for NSCLC with TNM system. Staging of SCLC with Veterans Administration Lung Study Group designations
38 Treatment of NSCLC Patients with stage I or II NSCLC should be treated with complete surgical resection whenever possible. Postoperative adjuvant chemotherapy has been shown to improve survival in patients with pathologic stage II disease and may have a role for patients with stage IB NSCLC. Not surgical candidates: R/T may be useful
39 Treatment of NSCLC For patients with pathologically proven stage III disease prior to definitive therapy, a combined modality approach using concurrent chemotherapy is generally preferred. Surgery following CT/RT may also retain a role for carefully selected patients with T3 or T4 lesions and negative mediastinal lymph nodes.
40 Treatment of NSCLC Patients with stage IV disease are generally treated with systemic therapy or a symptombased palliative approach. In appropriately selected patients, chemotherapy and/or molecularly targeted therapy may prolong survival without sacrificing quality of life. Radiation therapy and surgery may also be useful for symptom palliation in some patients.
41 Prognosis (NSCLC) Stage IA IB IIA IIB IIIA IIIB IV Five-year survival
42 Treatment of SCLC Patients with limited stage disease are primarily treated with a combination of chemotherapy and radiation therapy. Surgery is not used except in the rare patient who presents with a solitary pulmonary nodule without metastases or regional lymph node involvement.
43 Treatment of SCLC For patients with extensive stage SCLC, chemotherapy alone is used as the initial therapy. Prophylactic radiation has been shown to decrease the incidence of brain metastases and prolong survival in patients with both limited and extensive stage SCLC who respond to their initial treatment
44 Prognosis of SCLC Patients with limited stage disease: Median survivals: 15~20 months Five-year survival rate: 10~13% Patients with extensive stage SCLC: Median survival: 8~13 months Five-year survival rate: 1~2%
45 Reference Robbins Pathologic Basis of Disease 6/e Chest X-ray made easy 2/e UpToDate: 1. Overview of the risk factors, pathology, and clinical manifestations of lung cancer. 2. Diagnosis and staging of non-small cell lung cancer. 3. Pathobiology and staging of small cell carcinoma of the lung. 4. Overview of the initial evaluation, treatment and prognosis of lung cancer. Images came from Google.
Small Cell Lung Cancer Types of Lung Cancer Non-small cell carcinoma (NSCC) (87%) Adenocarcinoma (38%) Squamous cell (20%) Large cell (5%) Small cell carcinoma (13%) Small cell lung cancer is virtually
PATIENT EDUCATION patienteducation.osumc.edu Lung Cancer: Diagnosis, Staging and Treatment Cancer begins in our cells. Cells are the building blocks of our tissues. Tissues make up the organs of the body.
PATIENT EDUCATION patienteducation.osumc.edu Lung Cancer: Diagnosis, Staging and Treatment Cancer starts in our cells. Cells are the building blocks of our tissues. Tissues make up the organs of the body.
Male Female Death rates from lung cancer in USA Smoking represents an interesting combination of an entrenched industry and a clearly drug-induced cancer Tobacco Use in the US, 1900-2000 5000 100 Per Capita
GUIDELINES FOR THE MANAGEMENT OF LUNG CANCER BY Ali Shamseddine, MD (Coordinator); email@example.com Fady Geara, MD Bassem Shabb, MD Ghassan Jamaleddine, MD CLINICAL PRACTICE GUIDELINES FOR THE TREATMENT
Lung Cancer What is cancer? First, some background on the way the body is built. Organs, like the heart, liver, and lung, are made up of tissues, such as blood vessels and muscle. Tissues, in turn, are
Neoplasms of the LUNG and PLEURA 2015-2016 FCDS Educational Webcast Series Steven Peace, BS, CTR September 19, 2015 2015 Focus o Anatomy o SSS 2000 o MPH Rules o AJCC TNM 1 Case 1 Case Vignette HISTORY:
Treatment Algorithms for the Management of Lung Cancer in NSW Guide for Clinicians Background The Cancer Institute New South Wales Oncology Group Lung (NSWOG Lung) identified the need for the development
General Information About Non-Small Cell Lung Cancer Non-small cell lung cancer is a disease in which malignant (cancer) cells form in the tissues of the lung. The lungs are a pair of cone-shaped breathing
Kidney Cancer OVERVIEW Kidney cancer is the third most common genitourinary cancer in adults. There are approximately 54,000 new cancer cases each year in the United States, and the incidence of kidney
GUIDE TO ASBESTOS LUNG CANCER What Is Asbestos Lung Cancer? Like tobacco smoking, exposure to asbestos can result in the development of lung cancer. Similarly, the risk of developing asbestos induced lung
A Practical Guide to Advances in Staging and Treatment of NSCLC Robert J. Korst, M.D. Director, Thoracic Surgery Medical Director, The Blumenthal Cancer Center The Valley Hospital Objectives Revised staging
LUNG CANCER FCDS 2011 Educational Webcast Series November 17, 2011 Judy Bonner, RN, MS, CTR and Lynne Pearson, CTR, LHRM Steven Peace, CTR Updated for 2011 Requirements and CSv02.03.02 1 Presentation Outline
Lung Cancer Radiation Therapy in the Treatment of Lung Cancer JMAJ 46(12): 537 541, 2003 Kazushige HAYAKAWA Professor and Chairman, Department of Radiology, Kitasato University School of Medicine Abstract:
Lung Cancer Introduction Lung cancer is the number one cancer killer of men and women. Over 165,000 people die of lung cancer every year in the United States. Most cases of lung cancer are related to cigarette
Updated June 2014 Derived and updated by consensus of members of the Providence Thoracic Oncology Program with the aid of evidence-based National Comprehensive Cancer Network (NCCN) national guidelines,
Stage I, II Non Small Cell Lung Cancer Best Results T1 (less 3 cm) N0 80% 5 year survival No Role Adjuvant Chemotherapy Radiation Therapy Reduces Local Recurrence No Improvement in Survival 1 Staging Mediastinal
Lung Cancer B. Dingle MD, FRCPC, Brian Yaremko MD,FRCPC, R. Ash, MD, FRCPC, P. Truong, MD, FRCPC EPIDEMIOLOGY The estimated incidence of lung cancer in Canada for 2007 is 23,300 with 12,400 occurring in
A912: Kidney, Renal cell carcinoma General facts of kidney cancer Renal cell carcinoma, a form of kidney cancer that involves cancerous changes in the cells of the renal tubule, is the most common type
Why We re Here The lungs What is lung cancer? How common is it? Risks & symptoms Diagnosis & treatment options What Are Lungs? What Do They Do? 1 Located in the chest Allow you to breathe Provide oxygen
CE Objectives and Evaluation Form appear on page 235. An Overview of Lung Cancer Symptoms, Pathophysiology, And Treatment Linda H. Yoder Patients with lung cancer can provide treatment challenges for even
Welcome to Master Class for Oncologists Session 3: 2:45 PM - 3:30 PM Washington, DC March 28, 2009 Small Cell Lung Cancer: Best Practices & Recent Advances Speaker: Bruce E. Johnson, MD Professor of Medicine,
Protocol for Planning and Treatment The process to be followed in the management of: SMALL CELL LUNG CANCER Patient information given at each stage following agreed information pathway 1. DIAGNOSIS New
Avastin: Glossary of key terms Adenocarcinoma Adenoma Adjuvant therapy Angiogenesis Anti-angiogenics Antibody Antigen Avastin (bevacizumab) Benign A form of carcinoma that originates in glandular tissue.
Scan for mobile link. Lung Cancer Lung cancer usually forms in the tissue cells lining the air passages within the lungs. The two main types are small-cell lung cancer (usually found in cigarette smokers)
Non-Small Cell Lung Cancer John delcharco, MD (Statistics based on CVMC data 2009-2013) Statistics Lung cancer is the leading cause of cancer deaths in the United States. The American Cancer Society estimates
CHAPTER 4: LUNG CANCER DIAGNOSIS AND STAGING INTRODUCTION The lungs are vital organs. Working with the heart and circulatory system, they provide lifesustaining oxygen and rid the body of carbon dioxide.
Risk Management Plan PEMETREXED Powder for concentrate for Solution for infusion Pemetrexed is also indicated as monotherapy for the maintenance treatment of locally advanced or metastatic non small cell
بسم هللا الرحمن الرحيم Updates in Mesothelioma By Samieh Amer, MD Professor of Cardiothoracic Surgery Faculty of Medicine, Cairo University History Wagner and his colleagues (1960) 33 cases of mesothelioma
X-Rays Interpretation of Chest Radiographs Reynard McDonald, MD Medical Director NJMS Global Tuberculosis Institute When x-rays are produced and directed toward the patient, they may act in three basic
Lungenkrebs Prof. Dr. E.W. Russi Pneumologie 1.9.2008 Lungenkrebs Häufigkeit The Principles and Practice of Medicine William Osler New York D. Appleton and Company 1892 Section IV DISEASE OF THE RESPIRATORY
Renal Cancer: Symptoms, diagnosis, pathology & prognosis Mark Johnson Consultant Urological Surgeon Newcastle upon Tyne Hospitals NHS Foundation Trust Plan for today: How renal tumours present What investigations
LUNG CANCER: A CLINICIAN S PERSPECTIVE Michelle Wong Chris Hani Baragwanath Hospital IAEA PET/CT Workshop: Improving Patient Care 2 November 2010 EPIDEMIOLOGY OF LUNG CANCER Most common cause of cancer
Treatment Guide Lung Cancer Management The Chest Cancer Center at Cleveland Clinic, which includes specialists from the Respiratory Institute, Taussig Cancer Institute and Miller Family Heart & Vascular
Work-up of Suspected Lung Cancer Gordon Buduhan MD MSc FRCSC Section of Thoracic Surgery Lung Cancer Educational Program November 2013 Presenter disclosure No conflicts to disclose Scope of the problem
PET/CT in Lung Cancer Rodolfo Núñez Miller, M.D. Nuclear Medicine and Diagnostic Imaging Section Division of Human Health International Atomic Energy Agency Vienna, Austria GLOBOCAN 2012 #1 #3 FDG-PET/CT
Small Cell Lung Cancer Lung Practice Guideline Dr. Brian Dingle MSc, MD, FRCPC Approval Date: April 2007 Revised: November 2008 This guideline is a statement of consensus of the Thoracic Disease Site Team
Male Breast Cancer Introduction Breast cancer is cancer that starts in the cells of the breast. Breast cancer happens mainly in women. But men can get it too. Many people do not know that men can get breast
Basic Chest X-ray Interpretation Programme 2 In this second chest x-ray tutorial I will now start to look at some of the more commonly encountered pathologies. I have split this up into abnormalities involving
THYROID CANCER I. Introduction There are over 11,000 new cases of thyroid cancer each year in the US. Females are more likely to have thyroid cancer than men by a ratio of 3:1, and it is more common in
Pathology of lung cancer EASO COURSE ON LUNG CANCER AND MESOTHELIOMA DAMASCUS (SYRIA), MAY 3-4, 2007 Gérard ABADJIAN MD Pathologist Associate Professor, Saint Joseph University Pathology Dept. Hôtel-Dieu
The National Clinical Lung Cancer Audit (LUCADA) DATA MANUAL Title: Version: 3.1.5 Date: September 2013 LUCADA Lung Cancer Audit VERSION HISTORY Version Date Issued Brief Summary of Change Owner s Name
Basic Data 鍾 XX, female Age:59 y/o Chief complain for evaluation of the left pleural mass Clinical course This 59 years old lady Hypertension for 3 years, under herbal control. An episode of high BP up
The Radiology of TB Michael Lauzardo, MD MSc Director, Southeastern National Tuberculosis Center Chief, Infectious Diseases and Global Medicine University of Florida Objectives How to read a Chest X-Ray
Lung Carcinoid Tumor What are lung carcinoid tumors? Lung carcinoid tumors (also known as lung carcinoids) are a type of lung cancer, which is a cancer that starts in the lungs. Cancer starts when cells
Non-Small Cell Lung Cancer About Your Lungs and Lung Cancer How do your lungs work? To understand lung cancer it is helpful to understand your lungs. Your lungs put oxygen into the blood, which the heart
The Radiology of Tuberculosis David Ashkin, M.D., F.C.C.P. Medical Director, Southeastern National Tuberculosis Center Medical Director, Florida Bureau of TB and Refugee Health Clinical Assistant Professor,
Lung Cancer and Mesothelioma Robert Kratzke, M.D. John C. Skoglund Professor of Lung Cancer Research Section of Heme/Onc/Transplant Department of Medicine University of Minnesota Medical School Malignant
CHAPTER 6: TREATMENT FOR SMALL CELL LUNG CANCER INTRODUCTION This chapter provides an overview of treatment for small cell lung cancer (SCLC). Treatment options are presented based on the extent of disease.
UNDERSTANDING YOUR LUNG CANCER PATHOLOGY REPORT 1-800-298-2436 LungCancerAlliance.org A GUIDE FOR THE PATIENT 1 CONTENTS What is a Pathology Report?...3 The Basics...4 Sections of a Pathology Report...7
Invasive Staging for NSCLC Allan Pickens, MD Assistant Professor of Surgery Section of Thoracic Surgery Emory University Presentation 1600 1400 1200 1000 800 600 400 200 0 IA IB IIA IIB IIIA IIIB IV Stage
General Rules SEER Summary Stage 2000 Linda Mulvihill Public Health Advisor NCRA Annual Meeting May 2014 National Center for Chronic Disease Prevention and Health Promotion Division of Cancer Prevention
1. What is lung cancer? 2. How common is lung cancer? 3. What are the risk factors for lung cancer? 4. What are the signs and symptoms of lung cancer? 5. How is lung cancer diagnosed? 6. What are the available
The Need for Accurate Lung Cancer Staging Peter Baik, DO Thoracic Surgery Cancer Treatment Centers of America Oklahoma Osteopathic Association 115th Annual Convention Financial Disclosures: None 2 Objectives
Information Booklet for Patients Understanding Your Surgical Options for Lung Cancer Understanding Lung Cancer If you have just been diagnosed with lung cancer, this booklet will serve as an informational
Extensive-Stage Small Cell Lung Cancer Post Full-Course Chemotherapy with Residual Locoregional Cancer Disease: the Role and Treatment Consideration of Radiotherapy Case Number: RT2009-114(M) Potential
Change Presentation title and date in Footer dd.mm.yyyy Lung cancer case study Dr Jaishree Bhosle Consultant Medical Oncologist Change Presentation title and date in Footer dd.mm.yyyy 1 2 Part One Initial
Chapter 2 Staging of Breast Cancer Zeynep Ozsaran and Senem Demirci Alanyalı 2.1 Introduction Five decades ago, Denoix et al. proposed classification system (tumor node metastasis [TNM]) based on the dissemination
CD22 Antigen Is Broadly Expressed on Lung Cancer Cells and Is a Target for Antibody-Based Therapy Joseph M. Tuscano, Jason Kato, David Pearson, Chengyi Xiong, Laura Newell, Yunpeng Ma, David R. Gandara,
Main Page Risk Factors Reducing Your Risk Screening Symptoms Diagnosis Treatment Overview Chemotherapy Radiation Therapy Surgical Procedures Lifestyle Changes Managing Side Effects Talking to Your Doctor
Fibrous Tumor of the Pleura Milena Petranovic, HMS IV Gillian Lieberman, MD June 17, 2008 Our Patient: 39-year old asymptomatic female Mass on Chest X-ray PA BIDMC, PACS Lateral BIDMC, PACS Well-circumscribed,
GENERAL CODING When you review old cases that were coded to unknown, make corrections based on guidelines in effect at the time of diagnosis. Exception: You must review and revise EOD coding for prostate
Corso Integrato di Clinica Medica ONCOLOGIA MEDICA AA 2010-2011 LUNG CANCER. VIII. THERAPY. V. SMALL CELL LUNG CANCER Prof. Alberto Riccardi SMALL CELL LUNG CARCINOMA Summary of treatment approach * limited
Guideline for the Imaging of Patients Presenting with Breast Symptoms incorporating the guideline for the use of MRI in breast cancer Version History Version Date Summary of Change/Process 0.1 09.01.11
BIT's 4th World Cancer Congress 2011 People s Republic of China Dalian The Di Bella Method (DBM) improves Survival, Objective Response and Performance Status in treated with DBM therapy Retrospective observational
Dr. Anthony C.H. YING What are? Tumour markers are substances that can be found in the body when cancer is present. They are usually found in the blood or urine. They can be products of cancer cells or
Lung cancer A guide for journalists on Non-Small Cell Lung Cancer (NSCLC) and its treatment Contents Contents 2 3 Section 1: Lung Cancer 4 i. Types of lung cancer 4 ii. Causes and risk factors 5 iii. Symptoms
Lung Carcinoid Tumor What are lung carcinoid tumors? Lung carcinoid tumors (also known as lung carcinoids) are a type of lung cancer, which is a cancer that starts in the lungs. Cancer starts when cells
Patient Guide ASCOInformation for People Living with Cancer ADVANCED LUNG CANCER TREATMENT Recommendations of the American Society of Clinical Oncology Welcome The American Society of Clinical Oncology
Lung Cancer Understanding your diagnosis Lung Cancer Understanding your diagnosis When you first hear that you have cancer you may feel alone and afraid. You may be overwhelmed by the large amount of information
Renal Cell Carcinoma of the Left Kidney Post Radical Surgery with pt4 Classification with Multiple Lung and Single Brain Metastases: the Role and Treatment Consideration of Radiotherapy Case Number: RT2009-124(M)
An Update on Lung Cancer Diagnosis Dr Michael Fanning MBBS FRACGP FRACP RESPIRATORY AND SLEEP PHYSICIAN Mater Medical Centre Outline Risk factors for lung cancer Screening for lung cancer Radiologic follow-up
The TV Series www.healthybodyhealthymind.com Produced By: INFORMATION TELEVISION NETWORK ONE PARK PLACE 621 NW 53RD ST BOCA RATON, FL 33428 1-800-INFO-ITV www.itvisus.com 2005 Information Television Network.
Advances in Differentiated Thyroid Cancer Steven A. De Jong, M.D., FACS, FACE Professor and Vice Chair Clinical Affairs Department of Surgery Loyola University Medical Center Thyroid Cancer classification
CANCER FACTS N a t i o n a l C a n c e r I n s t i t u t e N a t i o n a l I n s t i t u t e s o f H e a l t h D e p a r t m e n t o f H e a l t h a n d H u m a n S e r v i c e s Mesothelioma: Questions
AATS Annual Meeting, Toronto, 2014. General Thoracic Session. Evolution of Staging in Lung Cancer Peter Goldstraw, Honorary Consultant Thoracic Surgeon, Royal Brompton Hospital, Emeritus Professor of Thoracic
RESEARCH EDUCATE ADVOCATE Just Diagnosed with Melanoma Now What? INTRODUCTION If you are reading this, you have undergone a biopsy (either of a skin lesion or a lymph node) or have had other tests in which
Abhishek Vadalia Introduction Chemoembolization is being used with increasing frequency in the treatment of solid hepatic tumors such as Hepatocellular Carinoma (HCC) & rare Cholangiocellular Carcinoma
2011 Radiology Diagnosis Coding Update Questions and Answers How can we subscribe to the Coding Clinic for ICD-9 guidelines and updates? The American Hospital Association publishes this quarterly newsletter.
A 65 year old man is admitted because of headache and blurry vision for the past few days. In the emergency room the physicians also notice that he has neck vein distension and darker coloration over his
This information is an extract from the booklet Understanding lung cancer. You may find the full booklet helpful. We can send you a free copy see page 7. The lungs Contents The lungs Types of lung cancer